Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06636994 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Anatomical and Functional Predictions of Blindsight Capabilities in Patients With Lateral Hemianopsia

Study acronym: PRE-SIGHT
StatusNot Yet Recruiting
PhaseNot specified
Started2026-10
View on ClinicalTrials.gov ↗

Amendment history

2026-10-02
notable
Trial status changed: Active, Not Recruiting → Not Yet Recruiting
Primary completion moved earlier: 2029-12 → 2029-10
Completion moved earlier: 2029-12 → 2029-10
2025-03-27
notable
Not Yet Recruiting→Active, Not Recruiting Study Identification, Study Status, Oversight, Conditions, Contacts/Locations v1
Trial statusNot Yet Recruiting→Active, Not Recruiting
Primary completion date2029-12-01→2029-12
Completion date2029-12-01→2029-12
Start dateestimated 2025-06-01→confirmed 2024-11-21
Study sitescontacts updated at 1 of 1 site
Study title-8 characters
Anatomical and Functional Predictions of Blindsight AbilitiesCapabilities in Patients With Homonymous Lateral Hemianopsia
2024-10-10
minor
Original filing
Homonymous lateral hemianopia (HLH) is characterized by loss of vision in half the visual field, and is the most common neurovisual disorder following stroke. Numerous behavioral and neuroanatomical studies have focused on the phenomenon of blindsight, corresponding to patients' unconscious residual visual capacities in the blind hemifield. Cohort studies of patients have highlighted different types of blindsight, and a low occurrence of the phenomenon initially described: (1) type 1 blindsight (≈12%), unconscious visual abilities; (2) type 2 blindsight, visual abilities associated with sensations in the blind field (≈18%); (3) blindsense, sensations in the blind field without visual abilities (≈30%); and (4) no blindsight (≈40%). The heterogeneity of these blindsight abilities in the HLH population is closely related to patients' neuroanatomical and functional profiles. In particular, resting-state functional imaging (r-fMRI) and default mode network analysis have highlighted a significant correlation between the degree of inter-hemispheric connection (between the healthy and injured hemispheres) and the rate of spontaneous visual field recovery. To our knowledge, this degree of functional connectivity has not yet been studied in relation to blindsight abilities. However, this functional MRI measurement tool represents a potential predictive factor for patients' residual performance in their blindsight field, in order to assess the level of visuo-cognitive impairment and, ultimately, to adapt care.
Trial Details
NCT Number NCT06636994
Lead Sponsor Fondation Ophtalmologique Adolphe de Rothschild
Conditions Homonymous Hemianopia, Stroke, Cortical Blindness, Hemianopia
Enrollment 50 participants
Start Date 2026-10
Primary Completion 2029-10 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2026-10-01